Pathological studies revealed mortality due to neoplastic disease conditions in 12.15% cases; with 7.79% in layers, 2.12% in broilers and 2.15% in dual purpose chicken breeds affecting mainly more than 18 weeks age group. Most of the affected chickens showed nonspecific clinical signs in the form of decreased feed intake, depression, emaciation and paleness. In contrary paralytic symptoms of the legs were not present and no lesions were detected in nerves, bursa of Fabricius, skin and eyes in our study.
Similar findings have also been observed by other researchers
(Sani et al., 2017) who reported that the overall prevalence of avian neoplastic diseases was 7.58% with overall prevalence of MD as 6.25%. They further added that the average age of poultry affected was 20.17 (SD=±2.6) weeks for MD and 41.43 (SD=±15.4) weeks for AL with weight loss (55.98%), ruffled feathers (47.01%), diarrhea (39.79%) and leg paralysis (17.52%) as the most reported clinical signs. In agreement to our findings clinical signs of poor growth and production have also been reported by various researchers
(Das et al., 2018). The existence of genetic resistance to MD among chickens and its influence on the outcome of MDV infection has been recognized since long (
Payne and Venugopal, 2000). Similar to our observations, it has been observed that the mortality in broiler breeder was more in females than males
(Eid et al., 2019); which indicate that the outcome of infection is influenced by sex, as females are usually more susceptible to the development of tumors (
Payne and Venugopal, 2000). The occurrence of MD in vaccinated flocks has also been reported by earlier workers
(Kamaldeep et al., 2007). Exposures to chicken anaemia virus infection, emergence of hyper virulent strains
(Raja et al., 2009), with further increase in the virulence of field strain suggested to be the cause of vaccination failure and pathological picture change of this neoplastic disease
(Gong et al., 2013). Incidence of MD in commercial layer flocks despite vaccination have also been related to vaccine failure consequent to prolonged exposure to high levels of trace elements, particularly lead and cadmium, leading to immunosuppression (
Muniyellappa et al., 2015).
Grossly, nodular enlargements in liver, spleen, lungs, kidneys, proventriculus, intestine and ovaries were histopathologicaly confirmed by the proliferation and infiltration of pleomorphic lymphomatous cells, suggestive of MD. Microscopic lesions in MD are consisting of diffusely proliferating small-to- medium lymphocytes, lymphoblasts and activated and primitive reticulum cells. Published data suggests that all tumors with uniform lymphoblast population can be of MD or LL
(Payne et al., 1976). In such cases, confirmatory diagnosis can be made based on immunocyto/histochemistry (Meq, IgM) and ruling-out virus infection (MDV/ALV) by PCR. Five cases in present study also revealed aggregates of uniform sized large lymphoid cells (lymphoblasts) suggestive of avian lymphoid leucosis (LL) indicating mixed infections of MD with ALV. Mixed infections need differentiation by a simultaneous immunoreactivity with both Meq and IgM for MD and LL specific immuno markers respectively. Histopathological evidence did not support the presence of reticuloendotheliosis (RE) type lesions in any case.
The results for TaqMan probe real time PCR indicated that 92.5% cases gave positive expression for MDV specific Meq gene; while 3 cases were undetermined. Amplification plot depicting CT (cycle threshold) values has been presented in Fig 1. The CT value ranged between14.69 to 35.9. 72.9% cases revealed CT value ³29 indicating strong positive, while 27.1% cases showed CT value between >29-37 indicating moderate positive result.
Results of nested PCR confirmed the presence of 583 bp product for MDV specific Meq gene which is depicted in Fig 2. Out of total 40 cases, 22 cases showed positive expression of Meq gene of Marek’s disease virus. On comparison, the sensitivity of TaqMan probe real time PCR was 92.5% in detecting MDV specific target gene (Meq) while it was only 55% in case of nested PCR. The findings were more or less in agreement to those of other workers
(Krol et al., 2007). Marek’s disease (MD) is caused by a cell-associated herpes virus and the genetic material of MDV is a linear, double stranded DNA molecule containing about 80 specific genes of MDV which encode peptides that have an essential significance for oncogenicity and pathogenicity. Main oncogenes are the products of gene Meq, pp38 and 132bp sequence. It was found that high loads of MDV DNA and expression of the MDV oncogene Meq were specific for MDV-induced lymphomas and valid criteria for MD diagnosis
(Gimeno et al., 2005). Researchers also established that the Meq gene is necessary for the development of tumors and therefore is a key gene in the pathogenesis of MD
(Lupiani et al., 2004). Molecular detection of MDV specific Meq gene DNA in tumors, especially neoplastic nodules consistent with gross and histopathological characteristics has been found to be reliable for MD diagnosis.
Real-time polymerase chain reaction (PCR) methods based on different detection systems can determine the MDV genome loads based on either relative
(Yunis et al., 2004) or absolute quantification
(Baigent et al., 2005). The importance of real time PCR is to precisely distinguish and measure specific nucleic acid sequences in a sample, even if there is only a very small amount of DNA. The sensitivity of the real-time assay was found to be 2.5–10 times more than that of conventional PCR. Results of present study also indicate more sensitivity of real time PCR than nested PCR for Marek’s disease diagnosis which is in agreement to the findings of
Dagher et al., (2004).
The result of immunohistochemical reactivity to B and T cell markers indicated that for CD3 antibody (T cell marker) was found to be positive in almost all MD positive cases with more than 90% cytoplasmic or membranous reactivity in neoplastic cells
i.e. both small and large lymphocytes (Fig 3). In cases suspected of mixed infections, having both pleomorphic and uniform large lymphoblast cells, positive reactivity was observed in few pleomorphic neoplastic cells only (Fig 4). No immunoreactivity for CD79 alpha was observed in MD cases (Fig 5) but in few cases there was positive membranous and cytoplasmic immunoreactivity in few large lymphocytes cells particularly at perivascular locations. Mixed infection cases, revealed positive immunohistochemical reactivity to CD79 alpha marker in 20 to 50% neoplastic cells particularly in large uniform immature lymphoblast cells (Fig 6) indicating the presence of B cells in tumor tissue. Results therefore support the utility of immunohistochemical staining besides the histological appearance in differentiating MD from other neoplastic diseases.
These findings were similar with the results of other researchers
(Mete et al., 2016 and
Eid et al., 2019). Negative immunoreactivity for CD79 alpha antibodies in pleomorphic lymphoid cells indicates that B cells did not comprise the neoplastic lymphoma lesions in MD. However, mixed infection cases indicate presence of both T and B cells in proliferating lymphomas. The findings were similar with the results of some workers
(Pejovic et al., 2007 and
Haridy et al., 2018) who revealed negative immunoreactivity of CD79 alpha in liver, kidney and spleen lymphomas in chickens and for CD20 (B-cell marker) and Pax5 (B-cell transcription factor) in white silkie fowl, respectively. According to our findings we also conclude that the CD3 cell population was dominant in MDV lesions. However, there were a modest percentage of CD79 alpha positive cells in the liver tumors, located perivascularly. In Marek’s disease B cells are infected with MDV during the cytolytic phase of infection. Therefore, B-cells do play an important role in MDV pathogenesis and their presence in MDV lymphomas was also previously reported
(Payne et al., 1976). The results could be helpful in diagnosing mixed infections of MD and LL as well. Reports on multiple oncogenic virus infections have been described in literature and at times ALV and REV have been detected as contaminants in Marek’s disease vaccines (
Zavala and Cheng, 2006).